The CHARM-Added trial: Adding candesartan to ACE inhibitor reduces mortality in heart failure [Classics Series]
1. Angiotensin-converting-enzyme (ACE) inhibitors had been shown to significantly reduce mortality in patients with heart failure, and it was hypothesized ...